Signal-dependent control of autophagy-related gene expression

Fulvio Chiacchiera1, Cristiano Simone

  • 1Laboratory of Signal-Dependent Transcription, Department of Translational Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti), Italy.

Methods in Enzymology
|February 17, 2009
PubMed

Insights

Cancer cells use autophagy for survival, but overactivating this process can trigger self-cannibalization and cell death. Targeting autophagy pathways offers a new strategy for treating apoptosis-resistant tumors.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Tumors develop from dysregulated signaling pathways, promoting uncontrolled proliferation and hindering cell differentiation.
  • Cancer cells adapt to stress and evade apoptosis by acquiring modifications that enhance survival mechanisms.
  • Autophagy, a cellular recycling process, supports cancer cell survival under nutrient or growth factor deprivation.

Purpose of the Study:

  • To explore the dual role of autophagy in cancer, acting as both a survival and a potential cell death mechanism.
  • To investigate signaling pathways regulating autophagy for potential therapeutic targeting.
  • To identify molecular targets for inducing cancer cell self-cannibalization in apoptosis-resistant tumors.

Main Methods:

  • Review of signaling pathways regulating autophagy in cancer.
  • Analysis of autophagy's role in cancer cell survival and death.
  • Exploration of pharmacological strategies to manipulate autophagy.

Main Results:

  • Autophagy is a conserved prosurvival mechanism exploited by cancer cells.
  • Overactivated autophagy can lead to cancer cell death via self-cannibalization.
  • Targeting autophagy pathways presents a promising therapeutic avenue.

Conclusions:

  • Understanding autophagy regulation is crucial for cancer therapy.
  • Pharmacological induction of autophagy-mediated self-cannibalization could treat apoptosis-resistant cancers.
  • Targeting autophagy offers a novel approach to combat tumor growth and enhance treatment efficacy.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...